No Data
Shareholders of He Family Ophthalmology (301103.SZ), Meixin Fund and Pengxin Fund, have collectively reduced their Shareholding by 0.6851 million shares.
He Shi Ophthalmology (301103.SZ) announced that the Shareholders Meixin Fund and Pengxin Fund have concluded their shareholding plans ahead of schedule, total...
He Eye Hospital (301103.SZ) issued a pre-loss announcement, expecting a net loss of 20.5 million yuan to 30.75 million yuan for the fiscal year 2024, turning from profit to loss.
He Eye Hospital (301103.SZ) released its performance forecast for 2024, the company expects that for the year 2024, the net profit attributable to...
Ho\'s Ophthalmology: 2024 performance forecast
He Eye Hospital (301103.SZ): Expansion prefers economically developed regions.
On January 14, Gelonghui reported that He’s Eye Hospital (301103.SZ) announced on the investor interaction platform that the areas prioritized for the company's expansion are economically developed regions, focusing on JING-JIN-JI, the Chengdu-Chongqing urban agglomeration, and the CNI Zhujiang Index, with Consumer Medical as the key area for expansion, planning to adopt a combination of self-built and franchise chain methods.
Following Recent Decline, Liaoning He Eye Hospital Group Co., LTD.'s (SZSE:301103) Top Shareholder CEO Wei He Sees Holdings Value Drop by 9.8%
He family ophthalmology (301103.SZ): Currently, the total revenue of hospitals outside the province has shown year-on-year growth, but it has not yet passed the cultivation period.
GraceLon November 20th | Heshi Ophthalmology (301103.SZ) stated in recent investor relations activities that the total revenue of hospitals outside the province has increased compared to the same period, but it has not yet passed the incubation period. When the number of outpatient services reaches a certain scale, the profit contribution of hospitals outside the province will also be significantly improved.
Liaoning He Eye Hospital Group (SZSE:301103) Could Be Struggling To Allocate Capital